
Johnson & Johnson
JNJ 234.34 (-0.45%) 1.05
Health Care
Pharmaceuticals
Quality Checklist 6/8
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
Quick Ratio > 1
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $564.11(B)
EV: $628.39(B)
Total Equity: $81.19(B)
Earnings date: Jul-14-2026
P/E: 26.81
Forward P/E: 20.24
P/FCF: 31.71
P/S: 5.86
P/B: 6.95
EPS: $8.7
EPS (fwd): $11.6
FCF/share: $7.4
Revenue/share: $40.0
Book value/share: $33.7
ROIC: 21.7%
ROA: 13.5%
ROE: 33.6%
Debt/Equity: 0.68
Current Ratio: 1.00
Gross margin: 68.0%
Operating margin: 26.2%
Net margin: 21.8%
Dividend/share: $5.2
Div. yield: 2.22%
TTM Financials
Income (TTM)
Revenue$96.36(B)
Gross profit$65.56(B)
EBITDA$34.33(B)
Net income$21.04(B)
Gross margin68.0%
Operating margin26.2%
Net margin21.8%
Shares outstanding2.41(B)
Balance sheet
Total assets$200.89(B)
Current assets$59.17(B)
Total liabilities$119.71(B)
Current liabilities$57.72(B)
Cash & Short-term inv.$22.05(B)
Long-term debt$37.53(B)
Total intangibles$97.62(B)
PP&E$23.27(B)
Cash flow (TTM)
FCF$17.78(B)
CapEx$-5.09(B)
Dividends paid$-12.52(B)
Stock issued$4.14(B)
Stock repurchased$-7.85(B)
Stock-based comp.$1.37(B)
Debt issued$18.24(B)
Debt repaid$-16.44(B)
